Cargando…
Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
Intravesical instillation of Bacillus Calmette-Guérin (BCG) is used for the treatment of superficial bladder cancer, both to reduce the recurrence rate of bladder tumour and to diminish the risk of progression. Since its first therapeutic application in 1976, major research efforts have been directe...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364784/ https://www.ncbi.nlm.nih.gov/pubmed/15266312 http://dx.doi.org/10.1038/sj.bjc.6602026 |